Pharma: Reform of the EU Pharmaceutical Legislation; German Medical Research Act enacted fostering R&D also including confidentiality of drug prices; France adopts standard CTA clauses; UK easing clinical trials; Devices:...more
Pharma: Launch of Shortages Monitoring Platform, several Changes re Clinical Trial Management in EU Countries; Devices: Resolution on the need to revise the MDR and IVDR published; Compliance: CSRD still not implemented in...more
First director disqualification: UK focus on pursuing individuals as well as companies for breach of competition law -
The UK's Competition and Markets Authority has secured its first disqualification of a director of a...more
1/18/2017
/ Anti-Competitive ,
Competition ,
Competition Authorities ,
Corporate Governance ,
EU ,
EU Market Abuse Regulation (EU MAR) ,
European Securities and Markets Authority (ESMA) ,
Financial Adviser ,
Financial Institutions ,
Financial Markets ,
Market Abuse ,
UK ,
UK Competition and Markets Authority (CMA)